FLULAVAL
STN: 125163
Proper Name: Influenza Vaccine
Tradename: FLULAVAL
Manufacturer: ID Biomedical Corporation of Quebec
Indications:
- For active immunization for the prevention of disease caused by influenza A subtype viruses and type B virus contained in the vaccine.
- FLULAVAL is approved for use in persons aged 6 months and older.
Product Information
Supporting Documents
- July 1, 2024 Approval Letter - FLULAVAL
- February 6, 2020 Approval Letter - FLULAVAL
- Statistical Review and Evaluation - FluLaval and FluLaval Quadrivalent
- Statistical Review Assay - FluLaval and FluLaval Quadrivalent
- Clinical Review - FluLaval and FluLaval Quadrivalent
- Supporting Documents older than three years - FluLaval